<p>美国股市近期表现不一，涨幅受到持续的关税不确定性和各公司财报差异的影响。对于愿意探索知名公司之外的投资者来说，便士股——通常与较小或较新的公司相关——仍然可以提供有趣的机会。尽管这个术语有些过时，但这些股票依然相关，因为在强劲的资产负债表和稳健的基本面支持下，它们在较低价格点上展现出增长潜力。</p>
<h3>美国十大便士股</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Safe Bulkers (NYSE:SB)</td>
<td>$3.36</td>
<td>$3.4913 亿</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Tuya (NYSE:TUYA)</td>
<td>$2.25</td>
<td>$13 亿</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Smith Micro Software (NasdaqCM:SMSI)</td>
<td>$1.06</td>
<td>$1848 万</td>
<td>✅ 4 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
<td>$3.20</td>
<td>$936 万</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Flexible Solutions International (NYSEAM:FSI)</td>
<td>$3.829</td>
<td>$4819 万</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>TETRA Technologies (NYSE:TTI)</td>
<td>$2.62</td>
<td>$3.2701 亿</td>
<td>✅ 5 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>BAB (OTCPK:BABB)</td>
<td>$0.8099</td>
<td>$581 万</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>QuantaSing Group (NasdaqGM:QSG)</td>
<td>$3.08</td>
<td>$2.6374 亿</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Lifetime Brands (NasdaqGS:LCUT)</td>
<td>$3.71</td>
<td>$8245 万</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>CBAK Energy Technology (NasdaqCM:CBAT)</td>
<td>$0.74</td>
<td>$6530 万</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们美国便士股筛选器的 761 只股票完整列表。</p>
<p>以下是筛选器中的一些选择。</p>
<h2>QuantaSing Group (NasdaqGM:QSG)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> QuantaSing Group Limited 在中国提供在线学习服务，市值约为 2.6374 亿美元。</p>
<p><strong>运营：</strong> 该公司在中国的运营收入为 34.8 亿人民币。</p>
<p><strong>市值：</strong> $2.6374 亿</p>
<p>QuantaSing Group Limited 市值为 2.6374 亿美元，专注于中国的在线学习领域，显示出显著的盈利增长，过去一年盈利增长 107.7%。尽管其股价波动较大且董事会经验不足，但 QuantaSing 的交易价格大幅低于其估计的公允价值，并保持强劲的财务健康，零债务且充足的短期资产覆盖负债。该公司在最近六个月报告销售额为 15.4 亿人民币，但预计未来三年盈利将下降。</p>
<ul>
<li>点击这里访问我们的完整财务健康分析报告，以了解 QuantaSing Group 的动态。</li>
<li>通过查看我们的增长报告，获取对 QuantaSing Group 未来方向的见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/95f4d8eb-3935-418d-9447-ab4d6ce40792/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/95f4d8eb-3935-418d-9447-ab4d6ce40792/chart/revenue-and-expenses-breakdown"/></p>
<p>截至 2025 年 4 月的 NasdaqGM:QSG 收入与支出细分</p>
<h2>Gossamer Bio (NasdaqGS:GOSS)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Gossamer Bio, Inc. 是一家临床阶段的生物制药公司，致力于开发和商业化用于治疗美国肺动脉高压的 seralutinib，市值为 2.0332 亿美元。</p>
<p><strong>运营：</strong> 该公司的收入主要来自其制药部门，总计 1.147 亿美金。</p>
<p><strong>市值：</strong> $2.0332 亿</p>
<p>Gossamer Bio, Inc. 市值为 2.0332 亿美元，专注于开发肺动脉高压的治疗方案。尽管目前尚未盈利，且预计在未来三年内不会实现盈利，但 Gossamer 在过去五年中每年减少了 12.8% 的亏损。其短期资产为 3.099 亿美元，超过短期和长期负债，表明相对于债务义务的强劲财务健康。最近的盈利显示，净亏损从 1.7982 亿美元减少到 5653 万美元，2024 年收入达到 1.147 亿美元，反映出在股价高度波动中持续的运营进展。</p>
<ul>
<li>通过我们的综合资产负债表健康报告深入了解 Gossamer Bio 的复杂性。</li>
<li>通过我们的详细增长报告评估 Gossamer Bio 未来的盈利预期。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0e7368f8-d1cb-4760-b556-aa2d18778279/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0e7368f8-d1cb-4760-b556-aa2d18778279/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 4 月的 NasdaqGS:GOSS 债务与股本历史及分析</p>
<h2>Vista Gold (NYSEAM:VGZ)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Vista Gold Corp.及其子公司是一家专注于澳大利亚黄金矿业的开发阶段公司，市值约为 1.179 亿美元。</p>
<p><strong>运营：</strong> Vista Gold Corp. 目前没有报告任何收入细分。</p>
<p><strong>市值：</strong> $1.179 亿</p>
<p>Vista Gold Corp. 市值约为 1.179 亿美元，已转向盈利，2024 年报告净收入 1125 万美元，而前一年为净亏损。公司的股本回报率高达 62.8%，且保持无债务，周波动稳定。尽管尚未产生收入，Vista Gold 的潜力因其在澳大利亚 Mt Todd 项目的有希望的钻探结果而增强，这可能增加黄金矿藏储量并改善未来前景。经验丰富的管理层和董事会进一步增强了其在竞争激烈的矿业领域的地位。</p>
<ul>
<li>解锁我们对 Vista Gold 股票分析的全面见解，查看此财务健康报告。</li>
<li>检查 Vista Gold 的过往业绩报告，以了解其在过去几年的表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/67ea27c1-9857-411a-b06d-a422d7c3fae9/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/67ea27c1-9857-411a-b06d-a422d7c3fae9/chart/financial-position-analysis"/></p>
<p>截至 2025 年 4 月的 NYSEAM:VGZ 财务状况分析</p>
<h2>利用机会</h2>
<ul>
<li>深入了解我们在这里识别的 761 只美国便士股票。</li>
<li>对其他可能性感兴趣？今天最好的人工智能股票可能不止于像 Nvidia 和 Microsoft 这样的巨头。通过这 24 家专注于人工智能的小型公司，寻找下一个重大机会，这些公司在机器学习、自动化和数据智能方面的早期创新具有强大的增长潜力，可能为您的退休提供资金。</li>
</ul>
<p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章不构成财务建议。</strong> 它不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<p>如果您想交易 QuantaSing Group，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
<p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
<p>享受无隐藏费用，无账户最低限额，外汇转换率低至 0.03%，远远优于大多数经纪商提供的服务。</p>
<p>赞助内容</p>

GOSS

量子之歌

Vista黄金

HERE

<p>这篇文章讨论了三只前景看好的低价股，市值均超过 1 亿美元：量子之歌（QuantaSing Group）、Gossamer Bio 和 Vista 黄金（Vista Gold）。量子之歌的市值为 2.6374 亿美元，专注于中国的在线学习，并显示出显著的盈利增长。Gossamer Bio 的市值为 2.0332 亿美元，专注于治疗肺动脉高压，但仍处于亏损状态。Vista 黄金的市值为 1.1790 亿美元，是一家位于澳大利亚的开发阶段黄金矿业公司，最近已转向盈利。文章强调了在持续的市场不确定性中，这些股票的潜力</p>

<p>Stocks in the United States have been mixed recently, with gains tempered by ongoing tariff uncertainties and varying corporate earnings reports. For investors willing to explore beyond the well-known names, penny stocks—often associated with smaller or newer companies—can still offer intriguing opportunities. Despite being a somewhat outdated term, these stocks remain relevant as they present potential for growth at lower price points when supported by strong balance sheets and solid fundamentals.</p>
<div class="lb-trans"><p>美国股市近期表现不一，涨幅受到持续的关税不确定性和各公司财报差异的影响。对于愿意探索知名公司之外的投资者来说，便士股——通常与较小或较新的公司相关——仍然可以提供有趣的机会。尽管这个术语有些过时，但这些股票依然相关，因为在强劲的资产负债表和稳健的基本面支持下，它们在较低价格点上展现出增长潜力。</p>
</div><h3>Top 10 Penny Stocks In The United States</h3>
<div class="lb-trans"><h3>美国十大便士股</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Safe Bulkers (NYSE:SB)</td>
<td>$3.36</td>
<td>$349.13M</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Tuya (NYSE:TUYA)</td>
<td>$2.25</td>
<td>$1.3B</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Smith Micro Software (NasdaqCM:SMSI)</td>
<td>$1.06</td>
<td>$18.48M</td>
<td>✅ 4 ⚠️ 4 View Analysis &gt;</td>
</tr>
<tr>
<td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
<td>$3.20</td>
<td>$9.36M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Flexible Solutions International (NYSEAM:FSI)</td>
<td>$3.829</td>
<td>$48.19M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>TETRA Technologies (NYSE:TTI)</td>
<td>$2.62</td>
<td>$327.01M</td>
<td>✅ 5 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>BAB (OTCPK:BABB)</td>
<td>$0.8099</td>
<td>$5.81M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>QuantaSing Group (NasdaqGM:QSG)</td>
<td>$3.08</td>
<td>$263.74M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Lifetime Brands (NasdaqGS:LCUT)</td>
<td>$3.71</td>
<td>$82.45M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>CBAK Energy Technology (NasdaqCM:CBAT)</td>
<td>$0.74</td>
<td>$65.3M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Safe Bulkers (NYSE:SB)</td>
<td>$3.36</td>
<td>$3.4913 亿</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Tuya (NYSE:TUYA)</td>
<td>$2.25</td>
<td>$13 亿</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Smith Micro Software (NasdaqCM:SMSI)</td>
<td>$1.06</td>
<td>$1848 万</td>
<td>✅ 4 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
<td>$3.20</td>
<td>$936 万</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Flexible Solutions International (NYSEAM:FSI)</td>
<td>$3.829</td>
<td>$4819 万</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>TETRA Technologies (NYSE:TTI)</td>
<td>$2.62</td>
<td>$3.2701 亿</td>
<td>✅ 5 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>BAB (OTCPK:BABB)</td>
<td>$0.8099</td>
<td>$581 万</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>QuantaSing Group (NasdaqGM:QSG)</td>
<td>$3.08</td>
<td>$2.6374 亿</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Lifetime Brands (NasdaqGS:LCUT)</td>
<td>$3.71</td>
<td>$8245 万</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>CBAK Energy Technology (NasdaqCM:CBAT)</td>
<td>$0.74</td>
<td>$6530 万</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 761 stocks from our US Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们美国便士股筛选器的 761 只股票完整列表。</p>
</div><p>Here's a peek at a few of the choices from the screener.</p>
<div class="lb-trans"><p>以下是筛选器中的一些选择。</p>
</div><h2>QuantaSing Group (NasdaqGM:QSG)</h2>
<div class="lb-trans"><h2>QuantaSing Group (NasdaqGM:QSG)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> QuantaSing Group Limited offers online learning services in the People’s Republic of China and has a market capitalization of approximately $263.74 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> QuantaSing Group Limited 在中国提供在线学习服务，市值约为 2.6374 亿美元。</p>
</div><p><strong>Operations:</strong> The company generates its revenue of CN¥3.48 billion from operations within the People's Republic of China.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司在中国的运营收入为 34.8 亿人民币。</p>
</div><p><strong>Market Cap:</strong> $263.74M</p>
<div class="lb-trans"><p><strong>市值：</strong> $2.6374 亿</p>
</div><p>QuantaSing Group Limited, with a market cap of US$263.74 million, operates in the online learning sector in China and has shown significant profitability growth, achieving a 107.7% increase in earnings over the past year. Despite its volatile share price and inexperienced board, QuantaSing trades at a substantial discount to its estimated fair value and maintains strong financial health with no debt and ample short-term assets covering liabilities. The company reported CN¥1.54 billion in sales for the recent six months but faces forecasted earnings declines over the next three years.</p>
<div class="lb-trans"><p>QuantaSing Group Limited 市值为 2.6374 亿美元，专注于中国的在线学习领域，显示出显著的盈利增长，过去一年盈利增长 107.7%。尽管其股价波动较大且董事会经验不足，但 QuantaSing 的交易价格大幅低于其估计的公允价值，并保持强劲的财务健康，零债务且充足的短期资产覆盖负债。该公司在最近六个月报告销售额为 15.4 亿人民币，但预计未来三年盈利将下降。</p>
</div><ul>
<li>Click here and access our complete financial health analysis report to understand the dynamics of QuantaSing Group.</li>
<li>Gain insights into QuantaSing Group's future direction by reviewing our growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们的完整财务健康分析报告，以了解 QuantaSing Group 的动态。</li>
<li>通过查看我们的增长报告，获取对 QuantaSing Group 未来方向的见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/95f4d8eb-3935-418d-9447-ab4d6ce40792/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/95f4d8eb-3935-418d-9447-ab4d6ce40792/chart/revenue-and-expenses-breakdown"/></p>
<p>NasdaqGM:QSG Revenue &amp; Expenses Breakdown as at Apr 2025</p>
<div class="lb-trans"><p>截至 2025 年 4 月的 NasdaqGM:QSG 收入与支出细分</p>
</div><h2>Gossamer Bio (NasdaqGS:GOSS)</h2>
<div class="lb-trans"><h2>Gossamer Bio (NasdaqGS:GOSS)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing seralutinib for treating pulmonary arterial hypertension in the United States, with a market cap of $203.32 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Gossamer Bio, Inc. 是一家临床阶段的生物制药公司，致力于开发和商业化用于治疗美国肺动脉高压的 seralutinib，市值为 2.0332 亿美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily generated from its Pharmaceuticals segment, totaling $114.70 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司的收入主要来自其制药部门，总计 1.147 亿美金。</p>
</div><p><strong>Market Cap:</strong> $203.32M</p>
<div class="lb-trans"><p><strong>市值：</strong> $2.0332 亿</p>
</div><p>Gossamer Bio, Inc., with a market cap of US$203.32 million, is focused on developing treatments for pulmonary arterial hypertension. Despite being unprofitable and not expected to achieve profitability in the next three years, Gossamer has reduced its losses by 12.8% annually over the past five years. Its short-term assets of US$309.9 million exceed both short and long-term liabilities, indicating strong financial health relative to debt obligations. Recent earnings show a net loss reduction from US$179.82 million to US$56.53 million year-over-year, while revenue reached US$114.7 million in 2024, reflecting ongoing operational progress amidst high share price volatility.</p>
<div class="lb-trans"><p>Gossamer Bio, Inc. 市值为 2.0332 亿美元，专注于开发肺动脉高压的治疗方案。尽管目前尚未盈利，且预计在未来三年内不会实现盈利，但 Gossamer 在过去五年中每年减少了 12.8% 的亏损。其短期资产为 3.099 亿美元，超过短期和长期负债，表明相对于债务义务的强劲财务健康。最近的盈利显示，净亏损从 1.7982 亿美元减少到 5653 万美元，2024 年收入达到 1.147 亿美元，反映出在股价高度波动中持续的运营进展。</p>
</div><ul>
<li>Navigate through the intricacies of Gossamer Bio with our comprehensive balance sheet health report here.</li>
<li>Assess Gossamer Bio's future earnings estimates with our detailed growth reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过我们的综合资产负债表健康报告深入了解 Gossamer Bio 的复杂性。</li>
<li>通过我们的详细增长报告评估 Gossamer Bio 未来的盈利预期。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0e7368f8-d1cb-4760-b556-aa2d18778279/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/0e7368f8-d1cb-4760-b556-aa2d18778279/chart/debt-equity-history-analysis"/></p>
<p>NasdaqGS:GOSS Debt to Equity History and Analysis as at Apr 2025</p>
<div class="lb-trans"><p>截至 2025 年 4 月的 NasdaqGS:GOSS 债务与股本历史及分析</p>
</div><h2>Vista Gold (NYSEAM:VGZ)</h2>
<div class="lb-trans"><h2>Vista Gold (NYSEAM:VGZ)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Vista Gold Corp., along with its subsidiaries, is a development-stage company focused on the gold mining industry in Australia, with a market cap of approximately $117.90 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Vista Gold Corp.及其子公司是一家专注于澳大利亚黄金矿业的开发阶段公司，市值约为 1.179 亿美元。</p>
</div><p><strong>Operations:</strong> Vista Gold Corp. does not report any revenue segments at this time.</p>
<div class="lb-trans"><p><strong>运营：</strong> Vista Gold Corp. 目前没有报告任何收入细分。</p>
</div><p><strong>Market Cap:</strong> $117.9M</p>
<div class="lb-trans"><p><strong>市值：</strong> $1.179 亿</p>
</div><p>Vista Gold Corp., with a market cap of approximately US$117.90 million, has transitioned to profitability, reporting a net income of US$11.25 million for 2024 compared to a net loss the previous year. The company's return on equity is outstanding at 62.8%, and it remains debt-free with stable weekly volatility. Despite being pre-revenue, Vista Gold's potential is bolstered by promising drilling results at its Mt Todd project in Australia, which could increase gold mineral reserves and enhance future prospects. The seasoned management and board further strengthen its position in the competitive mining sector.</p>
<div class="lb-trans"><p>Vista Gold Corp. 市值约为 1.179 亿美元，已转向盈利，2024 年报告净收入 1125 万美元，而前一年为净亏损。公司的股本回报率高达 62.8%，且保持无债务，周波动稳定。尽管尚未产生收入，Vista Gold 的潜力因其在澳大利亚 Mt Todd 项目的有希望的钻探结果而增强，这可能增加黄金矿藏储量并改善未来前景。经验丰富的管理层和董事会进一步增强了其在竞争激烈的矿业领域的地位。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Vista Gold stock in this financial health report.</li>
<li>Examine Vista Gold's past performance report to understand how it has performed in prior years.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁我们对 Vista Gold 股票分析的全面见解，查看此财务健康报告。</li>
<li>检查 Vista Gold 的过往业绩报告，以了解其在过去几年的表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/67ea27c1-9857-411a-b06d-a422d7c3fae9/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/67ea27c1-9857-411a-b06d-a422d7c3fae9/chart/financial-position-analysis"/></p>
<p>NYSEAM:VGZ Financial Position Analysis as at Apr 2025</p>
<div class="lb-trans"><p>截至 2025 年 4 月的 NYSEAM:VGZ 财务状况分析</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用机会</h2>
</div><ul>
<li>Dive into all 761 of the US Penny Stocks we have identified here.</li>
<li>Interested In Other Possibilities? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 24 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.</li>
</ul>
<div class="lb-trans"><ul>
<li>深入了解我们在这里识别的 761 只美国便士股票。</li>
<li>对其他可能性感兴趣？今天最好的人工智能股票可能不止于像 Nvidia 和 Microsoft 这样的巨头。通过这 24 家专注于人工智能的小型公司，寻找下一个重大机会，这些公司在机器学习、自动化和数据智能方面的早期创新具有强大的增长潜力，可能为您的退休提供资金。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章不构成财务建议。</strong> 它不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><p>If you're looking to trade QuantaSing Group, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果您想交易 QuantaSing Group，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受无隐藏费用，无账户最低限额，外汇转换率低至 0.03%，远远优于大多数经纪商提供的服务。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>赞助内容</p>
</div>

3 只市值超过 1 亿美元的有潜力的便士股